Nobuharu Hanaoka
Papers
1
Total Citations
2
H-Index
1
About
Nobuharu Hanaoka is a leading figure in thoracic oncology, with a primary focus on lung cancers, malignant pleural mesotheliomas, and thymic epithelial tumors. His most significant contribution lies in the development of evidence-based medical practice guidelines, particularly as a key editor for the Japan Lung Cancer Society’s comprehensive 2024 guidelines. Hanaoka’s work on the chapter dedicated to thymic epithelial tumors has provided critical, standardized recommendations that shape clinical decision-making for these rare and complex malignancies. While his most-cited paper currently holds 2 citations, his impact is more profoundly measured by the widespread adoption of these guidelines in Japanese clinical practice, influencing treatment protocols for thousands of patients. His efforts bridge the gap between rigorous evidence synthesis and practical oncology, ensuring that even uncommon thoracic tumors receive standardized, high-quality care. Hanaoka’s dedication to guideline development underscores his role as a pivotal architect of modern thoracic oncology standards, making him an essential resource for clinicians and researchers navigating the nuances of lung and thymic cancer management.
Research Focus
Key Achievements
Top Papers
- 1